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aspiration was dry, and examination of the biopsy revealed
a hypoplastic marrow with myeloﬁbrosis (Fig. 1A and B).vailable online xxx
ntroduction
ypertrophic osteoarthropathy (HOA) is a condition presented
y arthralgia/arthritis, clubbing, and periosteal proliferation
periostitis) in long bones. It is classiﬁed as primary (hereditary
r idiopathic) and secondary. Primary HOA is a rare and hered-
tary condition observed mainly in children and adolescents.1
econdary HOA may be seen in the various systemic disorders
ncluding inﬂammatory and malign diseases. Clinical ﬁndings
evelop as a result of an increase in peripheral blood ﬂow as
ell as abnormal ﬁbroblast activity and proliferation.2–4
Myeloﬁbrosis is a chronic myeloproliferative disease char-Please cite this article in press as: Kelle B, et al. Coexistence of hypertro
http://dx.doi.org/10.1016/j.rbre.2014.11.004
cterized by clonal expansion of an abnormal hematopoietic
tem/progenitor cell.5 There are a few case reports regarding
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urkey.
∗ Corresponding author.
E-mail: bayramkelle@yahoo.com (B. Kelle).
ttp://dx.doi.org/10.1016/j.rbre.2014.11.004
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icenses/by-nc-nd/4.0/).the coexistence of myeloﬁbrosis with HOA. Here we present a
case of HOA coexisted with myeloﬁbrosis.
Case  report
Sixty-ﬁve years old male admitted to Physical Medicine and
Rehabilitation Outpatient Clinic due to increased pain at both
lower extremities for the preceeding year. He was diagnosed
myeloﬁbrosis as a result after medical history, routine blood
tests and bone marrow biopsy 6 years ago. Bone marrowphic osteoarthropathy and myeloﬁbrosis. Rev Bras Reumatol. 2016.
ine, Department of Physical Medicine and Rehabilitation, Adana,
Patient received interferon (IFN) alfa 2A during 2 years and his
bone marrow was in remission after this treatment. Although
e under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1 – Bone marrow biopsy shows reticulin-type myeloﬁbrosis (hematoxylin and eosin, 100×). Bone marrow biopsy shows
reticulin-type myeloﬁbrosis (reticulin, 100×).
patient’s pain has increased while moving, it has also per-
sisted at rest. Patient had beneﬁted from analgesic medication
initially but he stated that his pain increased over time, and
not resolved with analgesics. On the physical examination,
patient’s general status was well. Blood pressure was mea-
sured as 125/75 mmHg, and pulse rate was 78 min–1. Clubbing
was observed at both hands. Both tibias were painful by
percussion, and tibial margins were palpated as irregular.
Although pain was present at ankles and knees, no temper-
ature rise or synovitis were detected. Range of motion for
bilateral hip, knee and ankle joints were within the normal
limits.
Conventional X-ray of the cruris region demonstrated
periosteal reaction at both tibial bone which is more  promi-
nent on the left side (Fig. 2). Whole body bone scintigraphy
demonstrated increased uptake at distal part of left tibia. InPlease cite this article in press as: Kelle B, et al. Coexistence of hypertro
http://dx.doi.org/10.1016/j.rbre.2014.11.004
laboratory analysis, hemoglobin, white blood cell and platelet
counts were within normal limits, while MCV  was decreased
[69.5 fL – (N: 80–97–)]. Peripheral blood smear was assessed as
Fig. 2 – Periosteal reaction (periostitis) at the tibial margin
(black arrow).normal. There was not an increase in acute phase reactants.
Erythrocyte sedimentation rate was 20 mm/h  (N: 0–15) and CRP
was within normal range [<0.5 ng/L (N: 0–0.8)]. Parathyroid hor-
mone, calcium and 25-hydroxyvitamin D3 levels were within
normal limits. Serum IL-6 and TNF alfa levels were within
normal range.
Diagnosis was made as secondary HOA associated with
myeloﬁbrosis. Patient was recommended to receive oral
meloxicam 15 mg  daily. Because of the incomplete response
after seven days, colchicine 1 mg/day was added to the treat-
ment, and signiﬁcant decrease of pain was detected after one
week.
Discussion
HOA is a clinical syndrome characterized by digital clubbing
and periostal proliferation especially in the tibial bone.1 HOA
includes skin manifestations such as thickened skin on face
and scalp, and coarse facial features along with clubbing,
periostosis, acroosteolysis, and painful joint motion.6
HOA may be associated with various disorders including
intrathoracic malignancies, cyanotic heart diseases, gastroin-
testinal tumors and inﬂammatory bowel diseases.1 One of the
rare causes of secondary HOA is myeloﬁbrosis.
Mechanism of HOA formation is not fully understood.
Recent studies suggest the role of platelets.3 Platelet fragmen-
tation and aggregation as well as endothelial cell activation
lead to release of platelet derived growth factor (PDGF) and
other factors which induce connective tissue and periosteal
proliferation.3,7 PDGF plays an important role in the patho-
genesis of both myeloﬁbrosis and HOA.8 Increased levels of
PDGF, transforming growth factor beta (TGF-) and epidermal
growth factor (EGF) are present in alfa granules of megakary-
ocytes in the myeloﬁbrosis. Increased levels of TGF and EGF
cause excess production of collagen type III. This increase in
7phic osteoarthropathy and myeloﬁbrosis. Rev Bras Reumatol. 2016.
collagen type III causes clubbing and periostitis. Plasma levels
of pro-inﬂammatory cytokines such as tumor necrosis factor-
alfa (TNF-alfa), interleukin-6 (IL-6), and vascular endothelial
growth factor (VEGF) were also reported to be increased.9 One
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f the limitations of this case report was the lack of laboratory
ests including PDGF, TGF and VEGF. Nevertheless, TNF-alfa
nd IL-6 levels were negative in our patient.
HOA associated with myeloﬁbrosis is observed rarely and
 limited number of case reports are presented in the litera-
ure. Yu et al. presented two male with HOA associated with
yeloﬁbrosis. They suggested that periostitis, when associ-
ted with fever and bone pain, is indicative of more  aggressive
isease.10 In several case reports of HOA associated with
yeloﬁbrosis it has been reported that the acute phase reac-
ants were higher.2,3,7 Our patient had not fever and there was
o evidence of increased acute phase proteins. These points
ay be associated with the milder disease course of our case.
There is no evidence in the literature regarding that IFN
auses clinically overt HOA. But IFN therapy may cause club-
ing in some patients. There was only a published report
onsisting two patients who had clubbing associated with the
se of IFN treatment.11 It was reported that IFN treatment
auses abnormal ﬁbroblast activation and this condition may
e the cause clubbing. In this case report two patients were
resented who  received IFN alfa 2A for hepatitis C virus. Digital
lubbing was developed after the 2nd and 4th months of med-
cation in these patients, respectively. In contrast, our patient
as developed digital clubbing and tibial bone pain after 2
ears of medication. Nevertheless, there was a periosteal reac-
ion in both tibial bones in addition to clubbing in the current
ase which provided the diagnosis of HOA.
There is no consensus on the standard treatment regimen
f HOA. A favorable result to the combination of colchicine
nd meloxicam was observed in the present case. In the liter-
ture, it has been reported that pamidronate has been found
o be effective in osteoarthropaties not responding to nonste-
oidal anti-inﬂammatory drugs. Octreotide treatment has also
ielded similar results.12
In conclusion, patients who had diffuse joint pain with
nknown cause should be checked for comorbid conditions
nd additional diseases. In addition, HOA should be suggestive
n cases presented with atypical localized pain and clubbingPlease cite this article in press as: Kelle B, et al. Coexistence of hypertro
http://dx.doi.org/10.1016/j.rbre.2014.11.004
lready who had myeloﬁbrosis either in active or remission
eriod. However, it should be noted that all clinical ﬁndings
ay not be observed in cases of secondary or associated
OA.
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